Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

GE Healthcare Technologies Norway AS logo

GE Healthcare Technologies Norway AS

GE Healthcare provides technologies and services that are shaping a new age of healthcare

The Life Sciences business of GE Healthcare exists to enable and accelerate molecular and precision medicine. We do this by helping our customers discover, make and use new medicines.

Healthcare needs more precise diagnoses and treatments to improve patient outcomes, address the globally rising incidence of lifestyle and chronic diseases, and help reduce the $350 billion wasted each year on poorly-targeted medicines.

We empower researchers with the innovative tools and analytics to research and develop tomorrow’s therapeutics.

We drive productivity for the biopharmaceutical industry and help create manufacturing capacity in under-served markets.

We enable increasingly accurate diagnoses by providing advanced in vivo imaging agents & in vitro diagnostics.

We are helping create the future of regenerative medicine and cell therapy with customers by providing novel tools, technologies and methods.

We work on the things that matter to become trusted partners with our customers, combining our deep expertise, integrity, and heritage in diagnostics and biotechnology with an extensive global network and strength in infrastructure and services.

We are a multi-billion business of GE Healthcare serving researchers, pharmaceutical companies, and clinicians.

Core Imaging in Norway

GE Healthcare in Norway develops and manufactures injectable imaging agents including contrast media, representing more than $800 million in export sales annually.

The business employs more than 750 highly specialized employees at two sites, in Oslo and in Lindesnes on the south coast.  

In Oslo, more than 400 people engage in high-tech discovery, development and manufacturing of in-vivo Imaging Agents, covering all modalities (MR, X-ray, Ultrasound, SPECT and PET). The site is GE’s global Centre of Excellence for aseptic and small-scale API, and pilot scale manufacturing.

The plant in Lindesnes is a globally leading manufacturer of specialty chemicals and active pharmaceutical ingredients (API) for contrast media including Iohexol, Iodixanol, Gadodiamide and Gadoterate. The plant employs about 350 people, and produces thousands of tons a year, more than a third of the global market volume.

About GE Healthcare

Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.

Get in touch with us!

Visit us
Send us mail

Our published articles

No items found.
Date
Title
Category
No articles found.
GE Healthcare Technologies Norway AS

GE Healthcare Technologies Norway AS

GE Healthcare provides technologies and services that are shaping a new age of healthcare

The Life Sciences business of GE Healthcare exists to enable and accelerate molecular and precision medicine. We do this by helping our customers discover, make and use new medicines.

Healthcare needs more precise diagnoses and treatments to improve patient outcomes, address the globally rising incidence of lifestyle and chronic diseases, and help reduce the $350 billion wasted each year on poorly-targeted medicines.

We empower researchers with the innovative tools and analytics to research and develop tomorrow’s therapeutics.

We drive productivity for the biopharmaceutical industry and help create manufacturing capacity in under-served markets.

We enable increasingly accurate diagnoses by providing advanced in vivo imaging agents & in vitro diagnostics.

We are helping create the future of regenerative medicine and cell therapy with customers by providing novel tools, technologies and methods.

We work on the things that matter to become trusted partners with our customers, combining our deep expertise, integrity, and heritage in diagnostics and biotechnology with an extensive global network and strength in infrastructure and services.

We are a multi-billion business of GE Healthcare serving researchers, pharmaceutical companies, and clinicians.

Core Imaging in Norway

GE Healthcare in Norway develops and manufactures injectable imaging agents including contrast media, representing more than $800 million in export sales annually.

The business employs more than 750 highly specialized employees at two sites, in Oslo and in Lindesnes on the south coast.  

In Oslo, more than 400 people engage in high-tech discovery, development and manufacturing of in-vivo Imaging Agents, covering all modalities (MR, X-ray, Ultrasound, SPECT and PET). The site is GE’s global Centre of Excellence for aseptic and small-scale API, and pilot scale manufacturing.

The plant in Lindesnes is a globally leading manufacturer of specialty chemicals and active pharmaceutical ingredients (API) for contrast media including Iohexol, Iodixanol, Gadodiamide and Gadoterate. The plant employs about 350 people, and produces thousands of tons a year, more than a third of the global market volume.

About GE Healthcare

Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.

Get in touch with us!

Visit us
Send us mail

Our published articles

No items found.
Date
Title
Category
No articles found.